These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
870 related articles for article (PubMed ID: 31591683)
1. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683 [TBL] [Abstract][Full Text] [Related]
2. Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii. Zhang Y; Peng Y; Zhao L; Zhou G; Li X J Ethnopharmacol; 2021 Jun; 274():114033. PubMed ID: 33741440 [TBL] [Abstract][Full Text] [Related]
3. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin. Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839 [TBL] [Abstract][Full Text] [Related]
4. Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort. Yang T; Wu C; Li Y; Wang C; Mao Z; Huo W; Li J; Li Y; Xing W; Li L Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1619-1630. PubMed ID: 38653672 [TBL] [Abstract][Full Text] [Related]
5. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota. Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692 [TBL] [Abstract][Full Text] [Related]
6. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002 [TBL] [Abstract][Full Text] [Related]
7. Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial. Birkeland E; Gharagozlian S; Birkeland KI; Valeur J; Måge I; Rud I; Aas AM Eur J Nutr; 2020 Oct; 59(7):3325-3338. PubMed ID: 32440730 [TBL] [Abstract][Full Text] [Related]
8. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats. Yan H; Lu J; Wang Y; Gu W; Yang X; Yu J Phytomedicine; 2017 Mar; 26():45-54. PubMed ID: 28257664 [TBL] [Abstract][Full Text] [Related]
9. Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics. Nuli R; Azhati J; Cai J; Kadeer A; Zhang B; Mohemaiti P J Diabetes Res; 2019; 2019():2893041. PubMed ID: 31828159 [TBL] [Abstract][Full Text] [Related]
10. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids. Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709 [TBL] [Abstract][Full Text] [Related]
11. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India. Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058 [TBL] [Abstract][Full Text] [Related]
12. Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study. Verhaar BJH; Collard D; Prodan A; Levels JHM; Zwinderman AH; Bäckhed F; Vogt L; Peters MJL; Muller M; Nieuwdorp M; van den Born BH Eur Heart J; 2020 Nov; 41(44):4259-4267. PubMed ID: 32869053 [TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy. Wang Q; Chen C; Zuo S; Cao K; Li H J Transl Med; 2023 Jun; 21(1):395. PubMed ID: 37330571 [TBL] [Abstract][Full Text] [Related]
14. Metabolic profiles of oligosaccharides derived from four microbial polysaccharides by faecal inocula from type 2 diabetes patients. Xu J; Liu W; Wu J; Wang W; Wang Z; Yu X; Zhang H; Zhu L; Zhan X Int J Food Sci Nutr; 2021 Dec; 72(8):1083-1094. PubMed ID: 33870850 [No Abstract] [Full Text] [Related]
15. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites. Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238 [TBL] [Abstract][Full Text] [Related]
16. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Brunkwall L; Orho-Melander M Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033 [TBL] [Abstract][Full Text] [Related]
17. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease. Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373 [TBL] [Abstract][Full Text] [Related]
18. Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Li Q; Chang Y; Zhang K; Chen H; Tao S; Zhang Z Sci Rep; 2020 Mar; 10(1):5450. PubMed ID: 32214153 [TBL] [Abstract][Full Text] [Related]
19. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations. van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature. Li L; Chen L; Yang Y; Wang J; Guo L; An J; Ma X; Lu W; Xiao Y; Wang X; Dong Z Front Endocrinol (Lausanne); 2022; 13():890200. PubMed ID: 35757432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]